Following are major stock gainers on Nasdaq in Wednesday’s trading session:
Chembio Diagnostics, Inc. (NASDAQ:CEMI) was the active stock gainer on Wednesday and soared 159% to $5.34. Chembio Diagnostics is a biotech firm based in Hauppauge, New York that develops powerful diagnostic tools for medical applications the world over. The company keeps a global network of offices to ensure it can serve global clients, working from both Germany and Brazil.
This time last year, CEMI was trading at about the same price. It has seen a few spikes over that time related to news regarding its research, and it is currently recovering from a selloff earlier in the year.
NeuroMetrix, Inc. (NASDAQ:NURO) was another notable winner as the stock went up 107% to end the session at $20.80 after the U.S. Food and Drug Administration gave a “Breakthrough Designation” to the biopharma’s Quell device for treating fibromyalgia in adults. Under the FDA Breakthrough Device Program, the administration will provide NeuroMetrix with priority review and interactive communication regarding device development, through to commercialization.
Quell is an advanced, non-invasive, nerve stimulation device that is covered by 18 U.S. utility patents, the company said. The device is the only wearable neurostimulator that uses a custom designed microchip to provides high-power nerve stimulation in a form factor the size of a credit card, the company said.
Aehr Test Systems (NASDAQ:AEHR) surged 37.50% to $8.03 after the company said it received a $10.8 million order from its lead silicon-carbide test and burn-in customer. A company statement identified the client as a leading Fortune 500 semiconductor-device supplier with a focus on the automotive market. “This customer continues to forecast orders for multiple additional FOX systems and WaferPak Contactors this fiscal year and a significant number of systems and WaferPaks over the next several years due to electric-vehicle semiconductor test and burn-in demand,” Chief Executive Gayn Erickson said.